RNA疗法的创新:对最近的进展和新兴技术的回顾
Tuward J Dweh1, Glay Jr Eric Wulu2, John Kessellie Jallah3
1Faculty of Agriculture and Allied Sciences, C.V. Raman Global University, Bhubaneswar, India.
Nucleosides, nucleotides & nucleic acids
|January 13, 2025
概括
包括mRNA,RNAi和ASO在内的RNA疗法代表了生物医学科学的重大进步. 本综述分析了FDA批准的药物,突出了它们在治疗遗传疾病和癌症方面的潜力,同时指出了药物输送和稳定性的挑战.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于RNA的疗法已经成为生物医学科学的重要里程碑.
- 关键的RNA分子包括信使RNA (mRNA),RNA干扰 (RNAi) 和反感性寡核酸 (ASO).
研究的目的:
- 审查美国食品和药物管理局 (FDA) 批准的来自14家制药公司的RNA基药物.
- 分析目标基因,疾病,临床试验状态,输送方法和生产时间表.
- 确定RNA治疗开发的挑战和未来方向.
主要方法:
- 对基于RNA的治疗方法的FDA药物批准和临床试验数据的分析.
- 针对疾病的分类 (癌症,遗传疾病,病毒感染).
- 对药物输送系统 (病毒载体,纳米粒子) 和相关挑战的评估.
主要成果:
- 许多基于RNA的药物已被批准或正在等待批准,用于治疗各种疾病.
- 癌症治疗和遗传疾病是RNA治疗的重点领域.
- 像病毒载体和纳米粒子这样的传递系统被采用,但面临着挑战.
结论:
- RNA疗法证明了精准医学的变革潜力.
- 克服稳定性,非目标效应和细胞吸收方面的挑战至关重要.
- 创新的工程和传递技术对于推进RNA疗法至关重要.
相关概念视频
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
PCR - Polymerase Chain Reaction
Overview
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


